Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Conditions
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
South Coast Renal, Brockway House, Level 1, Suite 8, 82-86 Queen Street,, Southport, Gold Coast, Australia
Contact: Principal Investigator (Jagadeesh Kurtkoti)Concord Repatriation General Hospital, Concord, New South Wales, Australia
Contact: Study coordinator (Helen Clayton) · SLHD-ConcordRenalResearch@health.nsw.gov.au · + 61 2 9767 6576Contact: Principal Investigator (Shaundeep Sen)Liverpool Hospital, Clinic G-Reception 133, Level 1, Clinical Building, Burnside Drive, Liverpool, New South Wales, Australia
Contact: Principal Investigator (Angela Makris)Sydney Adventist Hospital, Wahroonga, New South Wales, Australia
Contact: Principal Investigator (Muhgeot Wong)Westmead Hospital, Clinical Research Unit, Level 6, B Wing/Building, Hawkesbury Road, Westmead, New South Wales, Australia
Contact: Principal Investigator (Gopala Rangan)Mater Hospital Brisbane, South Brisbane, Queensland, Australia
Contact: Principal Investigator (Michael Burke)St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
Contact: Principal Investigator (Veena Roberts, Dr)Sunshine Hospital, Western Centre for Health Research and Education, Level 3, 176-190 Furlong Road, Saint Albans, Victoria, Australia
Contact: Principal Investigator (Eugenia Pedagogos)Linear Clinical Research, Joondalup, Western Australia, Australia
Contact: Study coordinator (Brayden Ceravolo) · enquiries@linear.org.au; bceravolo@linear.org.au · 1300 546 327 / 08 6382 5110Contact: Principal Investigator (Dr Lara Hatchuel)Dr Hemant Kulkarni (Sub-investigator)Pacific Clinical Research Network Auckland, Takapuna, Auckland, New Zealand
Contact: Principal Investigator (Paul Hamilton, Dr)